MedPath

To understand the changes in genes present in the DNA during Cervical Cancer progressio

Not Applicable
Conditions
Health Condition 1: N72- Inflammatory disease of cervix uteri
Registration Number
CTRI/2018/11/016296
Lead Sponsor
Dr K Satyamoorthy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Case: Women aged between 21-65 years with pre-malignant and malignant cervical lesions are included in this study.

Control: Women aged between 21-65 years without any cervical lesions or symptoms are included as control participants.

Exclusion Criteria

Case: Women who are pregnant or lactating; who have undergone hysterectomy; who are diagnosed and have already started treatment for cervical lesions and malignancies are excluded from the study.

Control: Women who are pregnant or lactating; who have undergone hysterectomy; who are diagnosed and have already started treatment for cervical lesions and malignancies are excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath